rs550499593
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001166110.2(PALLD):c.121C>G(p.Pro41Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000431 in 1,497,448 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001166110.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000691 AC: 105AN: 151930Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00121 AC: 115AN: 94802Hom.: 0 AF XY: 0.00122 AC XY: 65AN XY: 53380
GnomAD4 exome AF: 0.000403 AC: 542AN: 1345410Hom.: 5 Cov.: 31 AF XY: 0.000432 AC XY: 287AN XY: 663666
GnomAD4 genome AF: 0.000684 AC: 104AN: 152038Hom.: 2 Cov.: 32 AF XY: 0.000861 AC XY: 64AN XY: 74330
ClinVar
Submissions by phenotype
not specified Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Pancreatic adenocarcinoma Benign:1
- -
PALLD-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at